The Phoenix Holdings Ltd.

Remuneration Information • Mar 16, 2025

Special Share Holders Assembly (April 21, 2025) - Options Grant to CEO in the Company and Options grant to CEO and Chairperson in subsidiary The Company has published an immediate report regarding a convening of a special Shareholders assembly to approve the grant of options to the Company's CEO, as well as the grant of options to the CEO & Company Chairperson in a subsidiary.The grant of option in the Company to the CEO will be carried out under the option grant outline published on March 13, 2025. Assuming full dilution, the exercised grant options will constitute 0.16% of the Company�s share capital.It should be noted that on March 13, 2025, under RSU outline, restricted stock units (RSUs) were also granted to employees in the Company and of subsidiaries. Assuming full dilution, these shares will constitute 0.23% of the Company�s share capital.See attached: Immediate Report and Voting Paper false

������ ������� ��"�	1 818
PHOENIX FINANCIAL LTD
Corporation no: 520017450	14969
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		�150 ( Public )		Reported via MAGNA:	16/03/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-01-017088	Time of broadcast: 07:57 07:57

---

English language report to Israeli corporateThis form is for reports that has been translated to English (convenience translation) and should be published alongside with the report in Hebrew in accordance with the Securities Regulations (Periodic and Immediate Reports), 5730 - 1970.

References of previous reports relating to this matter:   _________   _________   _________

_________

Attached hereto is a report on

Special Share Holders Assembly (April 21, 2025) - Options Grant to CEO in the Company and Options grant to CEO and Chairperson in subsidiary The Company has published an immediate report regarding a convening of a special Shareholders assembly to approve the grant of options to the Company's CEO, as well as the grant of options to the CEO & Company Chairperson in a subsidiary. The grant of option in the Company to the CEO will be carried out under the option grant outline published on March 13, 2025. Assuming full dilution, the exercised grant options will constitute 0.16% of the Company�s share capital. It should be noted that on March 13, 2025, under RSU outline, restricted stock units (RSUs) were also granted to employees in the Company and of subsidiaries. Assuming full dilution, these shares will constitute 0.23% of the Company�s share capital. See attached: Immediate Report and Voting Paper

2025__Special_Assembly_isa.pdf

	Reference to parallel Hebrew report:	2025-01-016869
	This report was not reported in Hebrew.

Details of the authorized signatories to sign on behalf of the corporation:

	Name of the signer	Corporate Role
1	Elad Sirkis	Secretary _________

Note: According to Rule 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these Regulations will be signed by the authorized persons to sign on behalf of the corporation. For the ISA staff notice Click here .2 2

note that the attached immediate report is a convenience translation only and the parallel Hebrew immediate report which was published on March 13, 2025 is the binding report.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: ������	Date of revision of form structure: 06/08/2024
Address: ��� ����� 53 , ������� 53454   , Tel: 03-7332997 , 03-7338174 Fax: 03-7238855
E-mail address: menin@fnx.co.il
Previous names of reporting entity: ������ ������ ��"�, ������ ������� ���� ����� ��"�
Name of the Signatory: ������ ���� Position of Signatory in the reporting corporation: Name of Employer Company: ������ ���� ������ ��"�
Address: ��� ����� 53 , ������� 5345433 Telephone: 074-7315656 Facsimile: 03-7238855 E-mail: Elads1@fnx.co.il 1